Quantitative Immunoassays
Product description
Intertek offers quantitative immunoassays such as ligand binding assays for toxicokinetic and pharmacokinetic studies supporting biologic preclinical and clinical development. Our capabilities for quantitative immunoassays include developing methods for biologics and biosimilars, method transfer, optimization and validation of existing methods (including kit assays) suitable for use in TK and PK studies. Utilizing a variety of detection platforms, including enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence (ECL), we follow Good Laboratory Practice (GLP) guidelines to provide accurate test results and verifiable, reproducible data that can assist you in compressing timelines whilst meeting the requirements for the drug approval process.
Read more
Specifications
| Categories | Laboratory and Analytical EquipmentBioanalysis; Contract Services - Analytical & Lab Services; Custom ManufacturingImmunochemistry |
|---|---|
| Sales markets | Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore) |
| Supplied from | United Kingdom |
Quantitative Immunoassays
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation